Adjunctive intravesical EDTA-tromethamine treatment of a biofilm-associated recurrent Escherichia coli cystitis in a dog.
Vincent LeynaudNicolas P JousserandMarie-Noëlle LucasLaurent CavaliéJean-Paul MottaÉric OswaldRachel LavouéPublished in: The Canadian veterinary journal = La revue veterinaire canadienne (2024)
A 15-month-old spayed female greater Swiss mountain dog was brought to our clinic because of relapsing episodes of urinary tract infection, present since her adoption at 2 mo of age. A diagnosis of chronic bacterial cystitis associated with an invasive, biofilm-forming uropathogenic Escherichia coli was made with bladder-wall histology and fluorescent in situ hybridization analysis. Local treatment with EDTA-tromethamine (EDTA-Tris) infusions along with parenteral cefquinome and prophylactic measures (Type-A proanthocyanidins and probiotics) coincided with clinical and bacterial remission. The dog has been free of clinical signs of urinary tract infection for >4 y. Biofilm-forming uropathogenic E. coli can cause chronic, recurrent cystitis due to low antibiotic efficacy and should be considered in cases of recurrent cystitis in dogs, especially in the absence of identified predisposing factors. This case report describes the diagnostic and therapeutic options that were used to manage a case of this type. Key clinical message: Fluorescent in situ hybridization analysis may be considered in the diagnosis of chronic bacterial cystitis in dogs, and intravesical instillations of EDTA-Tris may be helpful in managing such cases.
Keyphrases
- escherichia coli
- urinary tract infection
- biofilm formation
- pseudomonas aeruginosa
- staphylococcus aureus
- case report
- candida albicans
- multiple sclerosis
- quantum dots
- primary care
- klebsiella pneumoniae
- cystic fibrosis
- living cells
- disease activity
- spinal cord injury
- systemic lupus erythematosus
- drug induced
- muscle invasive bladder cancer